Patent · US Active

Feline pancreatic lipase

US8138316B2 · kind B2 · utility

0Cited by
31References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 10, 2010
Grant dateMar 20, 2012
Priority date
Expiry dateJun 10, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/40
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Isolated nucleic acid molecules having a nucleotide sequence encoding feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Isolated feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Host cells comprising a vector containing the polynucleotide sequences and methods for expressing the polypeptides. The generation of monoclonal antibodies that specifically binds to the feline pancreatic lipase polypeptides, and cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of feline pancreatic lipase in a biological sample. The methods include using standards or calibrators of recombinant feline pancreatic lipase to quantify the lipase in a sample. Devices and kits for performing methods for detecting feline pancreatic lipase in biological samples.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.